Browse the evidence

Rapamycin analogs (everolimus and temsirolimus) inhibit mTORC1 effectively but have a reduced impact on glucose tolerance compared to rapamycin.

If considering mTOR inhibition for longevity, discuss rapamycin analogs like everolimus or temsirolimus with your doctor. These drugs may provide similar anti-aging benefits (mTORC1 inhibition) with a lower risk of causing glucose intolerance compared to rapamycin.

Ethinyl Estradiol-Cyproterone Acetate (EE-CA) oral contraceptives significantly increase serum leptin and BMI in nonobese women with PCOS, despite improving hyperandrogenism.

EE-CA pills effectively lower testosterone in nonobese PCOS patients but may slightly increase body weight and significantly raise leptin levels. Patients should be aware of these metabolic changes while benefiting from improved menstrual cycles.

Dietary phytoestrogens (specifically soy isoflavones) do not significantly alter circulating testosterone, free testosterone, or estradiol levels in healthy adult men, refuting concerns that soy intake causes feminization or hypogonadism.

If you are a healthy man, you can consume soy products without worrying about your testosterone levels dropping or developing feminine traits. Large-scale reviews confirm soy intake does not alter your sex hormone balance.

Obesity and metabolic dysfunction are associated with significantly elevated circulating levels of extracellular vesicles (EVs), particularly those derived from platelets, endothelial cells, and adipocytes, which serve as biomarkers for metabolic stress and insulin resistance.

If you have obesity or metabolic syndrome, your body is likely releasing higher levels of extracellular vesicles (EVs) into your blood. These are not just waste; they carry signals that can worsen insulin resistance and inflammation. While there is no direct 'EV treatment' yet, lifestyle interventions like weight loss, diet, and exercise have been shown to reduce these elevated EV levels, suggesting that managing metabolic health directly impacts this signaling pathway.

Adipose tissue-derived extracellular vesicles (EVs) mediate communication between adipose tissue and other organs (like the liver), contributing to insulin resistance and systemic metabolic dysfunction in obesity.

Your fat cells are not just storage; they send signals to your liver and other organs via tiny vesicles. In obesity, these signals can promote insulin resistance. Improving your metabolic health through diet and exercise can normalize these signals, reducing the burden on your body's regulatory systems.

Adipose tissue macrophage (ATM)-derived EVs containing miR-155 contribute to glucose intolerance and insulin resistance by suppressing adipogenic transcription factors PPARγ and CEBPβ.

Immune cells in your fat tissue send out tiny vesicles that can affect how your body handles sugar. In obesity, these vesicles may carry specific RNA molecules that worsen insulin resistance. Losing weight can change the content of these vesicles, potentially improving your metabolic health.

Chronically elevated circulating GIP levels (approx. 15 ng/mL) improve glucose homeostasis, insulin sensitivity, and reduce diet-induced obesity and hepatic steatosis, whereas excessively high levels (>60 ng/mL) induce GIP resistance and negate these benefits.

This preclinical study suggests that maintaining moderate levels of the hormone GIP (around 15 ng/mL) may support healthy weight and blood sugar control, whereas extremely high levels might stop working. This highlights the importance of hormonal balance rather than just suppression or stimulation.

Calcium ions (Ca2+) regulate skeletal muscle plasticity and adaptation through slower, sustained shifts in cytosolic Ca2+ levels that activate specific signaling pathways, distinct from the rapid oscillations driving acute contraction.

To trigger muscle adaptation (like fiber type shifting or growth), you need to create specific calcium signaling patterns through your training style (e.g., volume, frequency), not just move heavy weights. The biochemical signal of calcium is the bridge between the mechanical act of exercise and the genetic instruction to change muscle structure.

Store-Operated Calcium Entry (SOCE) is a critical mechanism for sustaining contractility during repeated contractions and contributes to long-term muscle remodeling by enhancing gene expression via NFAT.

High-repetition or endurance-style training may be necessary to engage SOCE pathways, which support sustained force and contribute to muscle remodeling. Ignoring this may limit adaptations related to fatigue resistance and fiber type switching.

Phosphorylation of the Ryanodine Receptor 1 (RyR1) by CaMKII and PKA modulates channel activity, with hyperphosphorylation potentially leading to 'leaky' channels, increased open probability, and decreased contractility under resting conditions.

Excessive training stress or fatigue might lead to 'leaky' calcium channels due to phosphorylation changes, reducing force output. Recovery and proper training load management are essential to maintain channel integrity.

Gluconeogenesis from amino acids is a vital survival mechanism during starvation or low-carbohydrate intake, mobilizing muscle tissue to maintain blood glucose levels.

When you restrict carbohydrates or fast, your body makes glucose from non-carb sources, including amino acids from muscle. This is a normal survival mechanism. Combining this with adequate protein intake and resistance training helps minimize muscle loss during these periods.

In women with PCOS, increasing adiposity (BMI) significantly blunts LH pulse amplitude and mean LH levels, rendering LH-based diagnosis unreliable in obese subjects (BMI ≥ 30 kg/m²), whereas LH pulse frequency remains elevated regardless of BMI.

If you have PCOS symptoms (like irregular periods or high androgens) but your LH levels look normal, do not assume you are free of PCOS if you are overweight. Obesity suppresses LH levels in PCOS patients, masking the typical hormonal signature. Diagnosis should rely on other criteria (ultrasound, androgens) rather than LH alone if your BMI is 30 or higher.

Myostatin acts as a central negative regulator of skeletal muscle mass by inhibiting myoblast proliferation, increasing ubiquitin-proteasomal activity, and downregulating the IGF-Akt pathway.

Myostatin is a key biological brake on muscle growth. While you cannot directly control myostatin levels through simple lifestyle changes, understanding its role explains why muscle loss occurs in disease, aging, and disuse. Interventions that inhibit myostatin (currently experimental in humans) show potential for treating muscle-wasting diseases, but natural resistance training may chronically lower basal myostatin expression to facilitate hypertrophy.

Metformin treatment is associated with reduced cancer risk, potentially through AMPK activation and inhibition of mTOR.

Metformin is associated with reduced cancer risk in diabetic patients, possibly via AMPK/mTOR pathways. This is a potential therapeutic avenue, not a lifestyle recommendation.

Women with prior gestational diabetes mellitus (pGDM) exhibit significantly lower plasma adiponectin concentrations compared to women with normal glucose tolerance (NGT), independent of body fat mass and insulin sensitivity.

If you have a history of gestational diabetes, your body likely produces less of a protective hormone called adiponectin than women who did not have GDM, even if your weight is normal. This is a known risk factor for developing type 2 diabetes and cardiovascular issues. You should prioritize regular monitoring of your blood sugar and insulin sensitivity, as your body may be more prone to insulin resistance than the general population.

In insulin-resistant women with prior GDM, plasma adiponectin levels decrease further over a 1-year follow-up period, even in the absence of changes in body weight, body fat composition, or glucose tolerance.

If you have a history of GDM and are insulin-resistant, your protective adiponectin levels may drop over time even if you maintain your weight. This suggests that metabolic health can decline independently of body composition. Regular monitoring of insulin sensitivity is crucial to catch this decline early.

Lower plasma adiponectin in women with prior GDM is associated with subclinical inflammation, indicated by higher levels of C-reactive protein (CRP) and plasminogen activator inhibitor-1 (PAI-1).

Low adiponectin in women with a history of GDM is linked to higher levels of inflammation markers like CRP and PAI-1. This suggests that the hormonal imbalance contributes to a state of subclinical inflammation, which is a risk factor for cardiovascular disease.

Roux-en-Y gastric bypass (RYGB) induces type 2 diabetes remission primarily by restoring beta-cell glucose sensitivity, whereas improvements in insulin sensitivity are proportional to weight loss and do not independently predict remission.

For patients undergoing gastric bypass, weight loss alone does not guarantee diabetes remission. The key biological factor is the recovery of the pancreas's ability to sense and respond to glucose (beta-cell sensitivity). Patients with severe initial beta-cell dysfunction may not achieve remission even with significant weight loss. Monitoring metabolic markers beyond weight is crucial.

Home sleep monitoring devices can distinguish between obstructive and central sleep apnea phenotypes using cardiopulmonary coupling metrics, even without being approved for diagnosis.

If you have known sleep apnea, some advanced home monitors (like M1/SleepImage) may help distinguish between obstructive and central types using heart rate variability patterns, but this is not a diagnostic tool. Consult a physician for diagnosis and treatment.

In postmenopausal women, higher levels of bioavailable testosterone are associated with an increased risk of incident type 2 diabetes, but this association is entirely mediated by adiposity (BMI) and insulin resistance.

For postmenopausal women, high testosterone levels are a warning sign of metabolic risk, but they are not the root cause. The risk comes from excess body fat and insulin resistance. Managing weight and insulin sensitivity is the primary way to mitigate this risk, rather than targeting testosterone levels directly.

In postmenopausal women, higher levels of estradiol (E2) and lower levels of sex hormone-binding globulin (SHBG) are associated with an increased risk of incident type 2 diabetes, and these associations persist even after adjusting for adiposity and insulin resistance.

For postmenopausal women, both high estradiol and low SHBG are independent risk factors for type 2 diabetes, even if you are not overweight. These hormones may directly affect glucose metabolism. Monitoring these levels alongside standard metabolic markers can provide a more complete picture of diabetes risk.

Hypertrophic white adipocytes in obesity trigger chronic low-grade inflammation via macrophage infiltration, contributing to insulin resistance.

In obesity, fat cells can become so large that they trigger an inflammatory response, attracting immune cells that worsen insulin resistance. Reducing fat cell size through weight loss can help resolve this inflammation and improve metabolic health.

Insulin-resistant first-degree relatives of NIDDM patients exhibit a significantly higher percentage of type IIb muscle fibers compared to matched controls, and this morphological trait is a primary determinant of reduced insulin-stimulated glucose disposal.

If you have a family history of Type 2 diabetes, you may naturally have more fast-twitch (Type IIb) muscle fibers, which are less efficient at handling glucose under insulin stimulation. This is not a life sentence; the study links this trait to lower aerobic fitness. Prioritizing aerobic exercise (improving Vo2max) is a key strategy to counteract this specific morphological risk factor for insulin resistance.

Concurrent training for strength and endurance results in less adaptation (specifically reduced strength gains) compared to training for either modality alone, due to molecular interference between the PKB and AMPK signaling pathways.

If your primary goal is building muscle or strength, avoid long-duration endurance cardio immediately before or after your weights. If your primary goal is endurance, limit heavy resistance training. The molecular signals for muscle growth (PKB) and mitochondrial efficiency (AMPK) fight each other, so doing both optimally at the same time leads to inferior results for both.